| Date Filed | Type | Description |
| 10/03/2023 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 5,000 options to buy
@ $0.5677, valued at
$2.8k
|
|
| 03/07/2023 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 8,000 options to buy
@ $3.83, valued at
$30.6k
|
|
| 01/09/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/06/2023 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on Skye Bioscience, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.017, valued at
$4.3k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2021 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on Skye Bioscience, Inc.|
Txns:
| Granted 250,000 options to buy
@ $0.14, valued at
$35k
|
|
| 07/26/2021 |
3
| TYLE PRAVEEN (Director) has filed a Form 3 on Skye Bioscience, Inc. |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2020 |
4
| TYLE PRAVEEN (EVP, R&D) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 19,893 shares
@ $0
Paid exercise price by delivering 4,844 shares
@ $1.96, valued at
$9.5k
|
|
| 03/05/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2018 |
4
| TYLE PRAVEEN (EVP, R&D) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 728 shares
@ $8.53, valued at
$6.2k
Exercised 2,990 restricted stock units
@ $0 |
|
| 02/12/2018 |
4
| TYLE PRAVEEN (EVP, R&D) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 29,180 restricted stock units
@ $0
Granted 82,820 options to buy
@ $9.79, valued at
$810.8k
|
|
| 06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |